Bacil Pharma Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 0.09 | 0.11 | 0.06 |
| Operating Expense | 0.02 | 0.07 | 0.03 |
| Net Profit | -0.02 | 0.62 | 0.04 |
| Net Profit Margin | -22.22% | 563.64% | 66.67% |
| Earning Per Share | 0.22 | 0.44 | 0.03 |
| EBIDTA | -0.02 | 0.62 | 0.04 |
| Effective Tax Rate | 0% | 0% | 0% |
Particulars
Jun 2026
Revenue0.09
Operating Expense0.02
Net Profit-0.02
Net Profit Margin-22.22
Earning Per Share0.22
EBIDTA-0.02
Effective Tax Rate0
